Omada Health (NASDAQ:OMDA) President Sells $79,114.36 in Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 4,589 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $17.24, for a total value of $79,114.36. Following the transaction, the president owned 316,238 shares in the company, valued at $5,451,943.12. This trade represents a 1.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, April 8th, Wei-Li Shao sold 2,829 shares of Omada Health stock. The shares were sold at an average price of $12.71, for a total value of $35,956.59.

Omada Health Trading Up 2.3%

OMDA stock opened at $17.64 on Friday. The business’s fifty day moving average price is $15.73 and its 200 day moving average price is $14.78. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The company has a market capitalization of $1.05 billion and a PE ratio of -65.33.

Omada Health (NASDAQ:OMDA) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. Research analysts predict that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Barclays upped their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday, May 8th. Canaccord Genuity Group set a $24.00 price target on shares of Omada Health in a research report on Friday, May 8th. Needham & Company LLC restated a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research note on Friday, May 8th. The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, BMO Capital Markets decreased their target price on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, March 6th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Institutional Trading of Omada Health

Hedge funds have recently added to or reduced their stakes in the company. Perceptive Advisors LLC acquired a new position in Omada Health during the 2nd quarter worth approximately $44,402,000. Millennium Management LLC lifted its position in shares of Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares during the last quarter. Divisadero Street Capital Management LP purchased a new stake in shares of Omada Health during the 3rd quarter worth $30,510,000. Jefferies Financial Group Inc. acquired a new position in shares of Omada Health during the fourth quarter worth $16,948,000. Finally, SG Americas Securities LLC purchased a new position in Omada Health in the first quarter valued at $10,401,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.